Léčba Ewingova sarkomu/primitivního neuroektodermálního tumoru dospělých

Title in English Therapy for Ewing´s Family of Tumours in adults
Authors

ADÁMKOVÁ KRÁKOROVÁ Dagmar TUČEK Štěpán TOMÁŠEK Jiří JANÍČEK Pavel ČERNÝ Jaromír

Year of publication 2012
Type Article in Periodical
Magazine / Source Onkologie
MU Faculty or unit

Faculty of Medicine

Citation
Web http://www.onkologiecs.cz/pdfs/xon/2012/02/11.pdf
Field Oncology and hematology
Keywords Ewing s family of Tumours; multimodal therapy; toxicity; survival
Description Ewing's Family of Tumours is most frequently observed in children and adolescent age. 90 % of patiens are younger than 20 years. Prognosis is unfavourable, with 5-year overall survival from 55 to 70 % in localized, not exceeding 20 % in primarily metastatic disease. The results of the therapy are getting worse by increasing age. Multidisciplinary treatment planning is mandatory in all cases of this tumor. We introduce our experience with EURO E.W.I.N.G. 99/EWING 2008 protocol in adult patients.

You are running an old browser version. We recommend updating your browser to its latest version.

More info